EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling

eLife

Volumn 4, Issue NOVEMBER2015, 2015, Pages

  Baumdick, Martin ^a   Brüggemann, Yannick ^a,b   Schmick, Malte ^a   Xouri, Georgia ^a   Sabet, Ola ^a   Davis, Lloyd ^c   Chin, Jason W ^c   Bastiaens, Philippe I H ^a,b  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; TYROSINE; UBIQUITIN; EGFR PROTEIN, HUMAN;

ANIMAL CELL; ANISOTROPY; ARTICLE; AUTOCATALYSIS; CATALYSIS; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOSOME; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; MATHEMATICAL MODEL; NONHUMAN; PERICENTRIOLAR REGION; PHOSPHORYLATION; PROTEIN EXPRESSION; RNA INTERFERENCE; UBIQUITINATION; WESTERN BLOTTING; ANIMAL; CELL LINE; CYTOPLASM VESICLE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CYTOPLASMIC VESICLES; EPIDERMAL GROWTH FACTOR; HUMANS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84955255845     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.12223     Document Type: Article

References (67)

1. Arkhipov A, Shan Y, Das R, Endres NF, Eastwood MP, Wemmer DE, Kuriyan J, Shaw DE. 2013. Architecture and membrane interactions of the EGF receptor. Cell 152:557-569. doi: 10.1016/j.cell.2012.12.030
2. Arteaga CL, Engelman JA. 2014. ERBB receptors: from oncogene discovery to basic science to mechanism- based cancer therapeutics. Cancer Cell 25:282-303. doi: 10.1016/j.ccr.2014.02.025
3. Barbieri M. 2000. Epidermal growth factor and membrane trafficking: EGF receptor activation of endocytosis requires Rab5a. The Journal of Cell Biology 151:539-550. doi: 10.1083/jcb.151.3.539
4. Batzer AG, Blaikie P, Nelson K, Schlessinger J, Margolis B. 1995. The phosphotyrosine interaction domain of shc binds an LXNPXY motif on the epidermal growth factor receptor. Molecular and Cellular Biology 15:4403-4409. doi: 10.1128/MCB.15.8.4403
5. Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, Zerial M. 1992. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70:715-728. doi: 10.1016/0092-8674(92) 90306-W
6. Cantley LC. 2002. The phosphoinositide 3-kinase pathway. Science 296:1655-1657. doi: 10.1126/science.296. 5573.1655
7. Ceresa BP. 2006. Regulation of EGFR endocytic trafficking by rab proteins. Histology and Histopathology 21: 987-993.
8. Chung B, Raja SM, Clubb RJ, Tu C, George M, Band V, Band H. 2009. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with src@. BMC Cell Biology 10:84. doi: 10.1186/1471-2121-10-84
9. Cochet C, Kashles O, Chambaz EM, Borrello I, King CR, Schlessinger J. 1988. Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. The Journal of Biological Chemistry 263:3290-3295.
10. Di Guglielmo GM, Baass PC, Ou WJ, Posner BI, Bergeron JJ. 1994. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of raf-1 by EGF but not insulin in liver parenchyma. The EMBO Journal 13: 4269-4277.
11. Endres NF, Das R, Smith AW, Arkhipov A, Kovacs E, Huang Y, Pelton JG, Shan Y, Shaw DE, Wemmer DE, Groves JT, Kuriyan J. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152:543-556. doi: 10.1016/j.cell.2012.12.032
12. Fan Y-X, Wong L, Deb TB, Johnson GR. 2004. Ligand regulates epidermal growth factor receptor kinase specificity: Activation increases preference for GAB1 and SHC versus autophosphorylation sites. Journal of Biological Chemistry 279:38143-38150. doi: 10.1074/jbc.M405760200
13. Ferguson KM, Berger MB, Mendrola JM, Cho H-S, Leahy DJ, Lemmon MA. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Molecular Cell 11:507-517. doi: 10.1016/ S1097-2765(03)00047-9
14. Fritsche-Guenther R, Witzel F, Sieber A, Herr R, Schmidt N, Braun S, Brummer T, Sers C, Bluthgen N. 2011. Strong negative feedback from erk to raf confers robustness to MAPK signalling. Molecular Systems Biology 7:489. doi: 10.1038/msb.2011.27
15. Ghaderi J, Srikant R. 2013. Opinion dynamics in social networks: a local interaction game with stubborn agents. Am Control Conf:1982-1987.
16. Goh LK, Sorkin A. 2013. Endocytosis of receptor tyrosine kinases. Cold Spring Harbor Perspectives in Biology 5: a017459. doi: 10.1101/cshperspect.a017459
17. Grecco HE, Roda-Navarro P, Verveer PJ. 2009. Global analysis of time correlated single photon counting FRET- FLIM data. Optics Express 17:6493-6508. doi: 10.1364/OE.17.006493
18. Grecco HE, Schmick M, Bastiaens PIH. 2011. Signaling from the living plasma membrane. Cell 144:897-909. doi: 10.1016/j.cell.2011.01.029
19. Grøvdal LM, Stang E, Sorkin A, Madshus IH. 2004. Direct interaction of cbl with pTyr 1045 of the EGF receptor (eGFR) is required to sort the EGFR to lysosomes for degradation. Experimental Cell Research 300:388-395. doi: 10.1016/j.yexcr.2004.07.003
20. Haj FG. 2002. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 295:1708-1711. doi: 10.1126/science.1067566
21. Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C. 1997. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. Journal of Biological Chemistry 272:843-851. doi: 10.1074/jbc.272.2.843
22. Lai WH. 1989. Ligand-mediated autophosphorylation activity of the epidermal growth factor receptor during internalization. The Journal of Cell Biology 109:2751-2760. 6 . doi: 10.1083/jcb.109.6.2751
23. Lang K, Davis L, Torres-Kolbus J, Chou C, Deiters A, Chin JW. 2012. Genetically encoded norbornene directs site-specific cellular protein labelling via a rapid bioorthogonal reaction. Nature Chemistry 4:298-304. doi: 10. 1038/nchem.1250
24. Lang K, Davis L, Wallace S, Mahesh M, Cox DJ, Blackman ML, Fox JM, Chin JW. 2012. Genetic encoding of bicyclononynes and trans -cyclooctenes for site-specific protein labeling in vitro and in live mammalian cells via rapid fluorogenic diels-alder reactions. Journal of the American Chemical Society 134:10317-10320. doi: 10. 1021/ja302832g
25. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141:1117-1134. doi: 10. 1016/j.cell.2010.06.011
26. Leung Cheung AK, Yan Ip JC, Hang Chu AC, Cheng Y, Long Leong MM, Yee Ko JM, Shuen WH, Lung HL, Lung ML. 2015. PTPRG suppresses tumor growth and invasion via inhibition of akt signaling in nasopharyngeal carcinoma. Oncotarget 6:13434-13447. doi: 10.18632/oncotarget.3876
27. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y. 1999. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Molecular Cell 4:1029-1040. doi: 10.1016/S1097-2765(00)80231-2
28. Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y. 1998. C-Cbl/ Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes & Development 12:3663-3674. doi: 10.1101/gad.12.23.3663
29. Liao PS, Chen TS, Chung PC. 2001. A fast algorithm for multilevel thresholding. Journal of Information Science and Engineering 17:713-727.
30. Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, Ivaska J. 2005. Negative regulation of EGFR signalling through integrin-a1b1-mediated activation of protein tyrosine phosphatase TCPTP. Nature Cell Biology 7:78-85. doi: 10.1038/ncb1209
31. Moran MF, Koch CA, Anderson D, Ellis C, England L, Martin GS, Pawson T. 1990. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proceedings of the National Academy of Sciences of the United States of America 87:8622-8626. doi: 10.1073/pnas.87.21.8622
32. Offterdinger M, Bastiaens PI. 2008. Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane. Traffic 9:147-155. doi: 10.1111/j.1600-0854.2007.00665.x
33. Offterdinger M, Georget V, Girod A, Bastiaens PIH. 2004. Imaging phosphorylation dynamics of the epidermal growth factor receptor. Journal of Biological Chemistry 279:36972-36981. doi: 10.1074/jbc.M405830200
34. Okutani T, Okabayashi Y, Kido Y, Sugimoto Y, Sakaguchi K, Matuoka K, Takenawa T, Kasuga M. 1994. Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptors in intact cells. The Journal of Biological Chemistry 269:31310-31314.
35. Patterson GH. 2002. A photoactivatable GFP for selective photolabeling of proteins and cells. Science 297: 1873-1877. doi: 10.1126/science.1074952
36. Peschard P, Park M. 2003. Escape from cbl-mediated downregulation. Cancer Cell 3:519-523. doi: 10.1016/ S1535-6108(03)00136-3
37. Ravid T, Heidinger JM, Gee P, Khan EM, Goldkorn T. 2004. C-cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes. Journal of Biological Chemistry 279:37153-37162. doi: 10.1074/jbc.M403210200
38. Ravid T, Sweeney C, Gee P, Carraway KL, Goldkorn T. 2002. Epidermal growth factor receptor activation under oxidative stress fails to promote c-cbl mediated down-regulation. Journal of Biological Chemistry 277:31214-31219. doi: 10.1074/jbc.M204677200
39. Rink J, Ghigo E, Kalaidzidis Y, Zerial M. 2005. Rab conversion as a mechanism of progression from early to late endosomes. Cell 122:735-749. doi: 10.1016/j.cell.2005.06.043
40. Romsicki Y, Kennedy BP, Asante-Appiah E. 2003. Purification and characterization of t cell protein tyrosine phosphatase reveals significant functional homology to protein tyrosine phosphatase-1B. Archives of Biochemistry and Biophysics 414:40-50. doi: 10.1016/S0003-9861(03)00178-4
41. Rotin D, Margolis B, Mohammadi M, Daly RJ, Daum G, Li N, Fischer EH, Burgess WH, Ullrich A, Schlessinger J. 1992. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase c gamma. The EMBO Journal 11:559-567.
42. Rowinsky EK. 2004. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Annual Review of Medicine 55:433-457. doi: 10.1146/annurev.med.55.091902.104433
43. Sabet O, Stockert R, Xouri G, Brüggemann Y, Stanoev A, Bastiaens PIH. 2015. Ubiquitination switches EphA2 vesicular traffic from a continuous safeguard to a finite signalling mode. Nature Communications 6:8047. doi: 10.1038/ncomms9047
44. Selner NG, Luechapanichkul R, Chen X, Neel BG, Zhang Z-Y, Knapp S, Bell CE, Pei D. 2014. Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases. Biochemistry 53:397-412. doi: 10.1021/bi401223r
45. Shan Y, Eastwood MP, Zhang X, Kim ET, Arkhipov A, Dror RO, Jumper J, Kuriyan J, Shaw DE. 2012. Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization. Cell 149:860-870. doi: 10.1016/j.cell.2012.02.063
46. Shtiegman K, Kochupurakkal BS, Zwang Y, Pines G, Starr A, Vexler A, Citri A, Katz M, Lavi S, Ben-Basat Y, Benjamin S, Corso S, Gan J, Yosef RB, Giordano S, Yarden Y. 2007. Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. Oncogene 26:6968-6978. doi: 10.1038/sj.onc.1210503
47. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. 2007. The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 75:770-787. . doi: 10.1111/j.1432-0436. 2007.00238.x
48. Sigismund S, Algisi V, Nappo G, Conte A, Pascolutti R, Cuomo A, Bonaldi T, Argenzio E, Verhoef LGGC, Maspero E, Bianchi F, Capuani F, Ciliberto A, Polo S, Di Fiore PP. 2013. Threshold-controlled ubiquitination of the EGFR directs receptor fate. The EMBO Journal 32:2140-2157. doi: 10.1038/emboj.2013.149
49. Sigismund S, Woelk T, Puri C, Maspero E, Tacchetti C, Transidico P, Di Fiore PP, Polo S. 2005. Clathrin- independent endocytosis of ubiquitinated cargos. Proceedings of the National Academy of Sciences of the United States of America 102:2760-2765. doi: 10.1073/pnas.0409817102
50. Sonntag MH, Ibach J, Nieto L, Verveer PJ, Brunsveld L. 2014. Site-specific protection and dual labeling of human epidermal growth factor (hEGF) for targeting, imaging, and cargo delivery. Chemistry - a European Journal 20: 6019-6026. doi: 10.1002/chem.201304090
51. Sorkina T, Bild A, Tebar F, Sorkin A. 1999. Clathrin, adaptors and eps15 in endosomes containing activated epidermal growth factor receptors. Journal of Cell Science 112:317-327.
52. Squire A, Verveer PJ, Rocks O, Bastiaens PIH. 2004. Red-edge anisotropy microscopy enables dynamic imaging of homo-FRET between green fluorescent proteins in cells. Journal of Structural Biology 147:62-69. doi: 10. 1016/j.jsb.2003.10.013
53. Tarcic G, Boguslavsky SK, Wakim J, Kiuchi T, Liu A, Reinitz F, Nathanson D, Takahashi T, Mischel PS, Ng T, Yarden Y. 2009. An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Current Biology 19:1788-1798. doi: 10.1016/j.cub.2009.09.048
54. Thien CBF, Langdon WY. 1997. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the caenorhabditis elegans sli-1 gene. Oncogene 14:2239-2249. doi: 10. 1038/sj.onc.1201193
55. Ullrich O. 1996. Rab11 regulates recycling through the pericentriolar recycling endosome. The Journal of Cell Biology 135:913-924. doi: 10.1083/jcb.135.4.913
56. Ushiro H, Cohen S. 1980. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in a-431 cell membranes. The Journal of Biological Chemistry 255:8363-8365.
57. Vanlandingham PA, Ceresa BP. 2009. Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration. Journal of Biological Chemistry 284:12110-12124. doi: 10.1074/jbc. M809277200
58. Varma R, Mayor S. 1998. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394:798-801. doi: 10.1038/29563
59. Verveer PJ. 2000. Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science 290:1567-1570. doi: 10.1126/science.290.5496.1567
60. Vieira AV, Lamaze C, Schmid SL. 1996. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274:2086-2089. doi: 10.1126/science.274.5295.2086
61. Waterman H, Katz M, Rubin C, Shtiegman K, Lavi S, Elson A, Jovin T, Yarden Y. 2002. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. The EMBO Journal 21: 303-313. doi: 10.1093/emboj/21.3.303
62. Wouters FS, Bastiaens PIH. 1999. Fluorescence lifetime imaging of receptor tyrosine kinase activity in cells. Current Biology 9:1127-S1. doi: 10.1016/S0960-9822(99)80484-9
63. Yarden Y, Schlessinger J. 1987. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26:1443-1451. doi: 10.1021/bi00379a035
64. Yu F-SX, Yin J, Xu K, Huang J. 2010. Growth factors and corneal epithelial wound healing. Brain Research Bulletin 81:229-235. doi: 10.1016/j.brainresbull.2009.08.024
65. Yudushkin IA, Schleifenbaum A, Kinkhabwala A, Neel BG, Schultz C, Bastiaens PIH. 2007. Live-cell imaging of enzyme-substrate interaction reveals spatial regulation of PTP1B. Science 315:115-119. doi: 10.1126/science. 1134966
66. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125:1137-1149. doi: 10.1016/j.cell.2006.05.013
67. Zhang ZY, Maclean D, Thiemesefler AM, Roeske RW, Dixon JE. 1993. A continuous spectrophotometric and fluorometric assay for protein tyrosine phosphatase using phosphotyrosine-containing peptides. Analytical Biochemistry 211:7-15. doi: 10.1006/abio.1993.1224